Juan Pablo Alderuccio, MD¹, Alvaro J Alencar, MD², Jonathan H. Schatz, MD³, Russ Kuker, MD^4*, David Sicre, PharmD, MBA^5*, Georgios Pongas, MD^1*, Isildinha M. Reis, PhD^6*, Jay Y. Spiegel, MD, FRCPC¹, Laura Medina, MD^7*, Lazaros J. Lekakis^8*, Joseph S. Gyedu^7*, Jose Sandoval-Sus, MD⁹, Amer M. Beitinjaneh, MD, MS^10*, Michele D. Stanchina, DO, MS¹¹, Asaad Trabolsi, MD¹², Izidore S. Lossos, MD¹³, Joseph D. Rosenblatt, MD^14*, David S. Lessen, MD^7* and Craig H. Moskowitz, MD¹⁵

¹Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
²Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
³University of Miami, Miami, FL
⁴Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL
⁵Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
⁷Sylvester Comprehensive Cancer Center, Miami
⁸Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
⁹Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
¹⁰Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, FL
¹¹Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami, FL
¹²University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
¹³Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
¹⁴University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
¹⁵Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL

Noriko Fukuhara, MD, PhD¹, Dai Maruyama, MD, PhD², Kenichi Ishizawa, MD, PhD^3*, Yusuke Sano, MD^4*, Ryunosuke Machida^5*, Shinichi Makita^6*, Wataru Munakata, MD, PhD^6*, Satoshi Ichikawa, MD, PhD^7*, Keiko Aizawa, MD^8*, Kana Miyazaki, MD, PhD⁹, Yoshihiro Kameoka, MD, PhD^10*, Shinya Rai, MD, PhD¹¹, Yu Yagi, MD^12*, Naoki Takahashi, MD, PhD^13*, Toshiki Mushino^14*, Takeharu Kato, M.D., Ph.D.^15*, Yuri Miyazawa, MD, PhD^16*, Toko Saito, MD^17*, Kazuyuki Shimada, MD, PhD¹⁸, Junya Kuroda, MD, PhD¹⁹, Hideki Uryu, MD^20*, Yuko Mishima^2*, Nobuyuki Takayama²¹, Yasuhiro Suzuki, MD, PhD^22*, Toshiki Uchida, MD, PhD^23*, Nobuhiko Nakamura, MD, PhD^24*, Takayuki Tabayashi, MD, PhD^25*, Yosuke Minami, MD, PhD²⁶, Nobuaki Dobashi, MD, PhD²⁷, Kunihiro Tsukasaki, MD, PhD²⁸ and Hirokazu Nagai, MD, PhD²²

¹Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
²Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
³Division of Hematology, Yamagata University Hospital, Yamagata, JPN
⁴JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan
⁵Japan Clinical Oncology Group Datacenter/Operations Office, National Cancer Center, Tokyo, JPN
⁶Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
⁷Department of Hematology, Tohoku University Hospital, Sendai, Japan
⁸Division of Hematology, Yamagata University Hospital, Yamagata, Japan
⁹Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
¹⁰Department of Hematology, Nephrology, and Rheumatology, Akita University, Akita, AKI, JPN
¹¹Department of Hematology and Rheumatology, Kindai University Hospital, Osaka, Japan
¹²Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
¹³Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
¹⁴Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan
¹⁵Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
¹⁶Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan
¹⁷Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JPN
¹⁸Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
¹⁹Division of Hematology and Oncology, Department of Medicine,, Kyoto Prefectural University of Medicine, Kyoto, Japan
²⁰The Jikei University Hospital, Minato-ku, Tokyo, Japan
²¹Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Tokyo, Japan
²²Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, JPN
²³Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
²⁴Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
²⁵Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan
²⁶National Cancer Center Hospital East, Kashiwa, Japan
²⁷Division of Clinical Oncology/Hematology, The Jikei University Daisan Hospital, Tokyo, Japan
²⁸Department of Hematology, Saitama Medical University International Medical Center, Saitama, Japan

Simone Ferrero, MD^1,2, Ilaria Del Giudice^3*, Sara Galimberti, MD^4*, Valter Gattei, MD⁵, Luigi Marcheselli^6*, Elisa Genuardi^2*, Daniela Drandi^2*, Mariapia Pironti, MD^2*, Irene Dogliotti, MD^1*, Aurora Maria Civita^2*, Irene Della Starza, PhD^3,7*, Giovanni Manfredi Assanto^3*, Francesca Guerrini^4*, Clara Bono^4*, Riccardo Bomben, PhD^5*, Carola Boccomini^8*, Lucia Farina^9*, Jacopo Olivieri, MD^10*, Luca Arcaini, MD^11*, Federica Cavallo^1,2*, Filippo Ballerini^12*, Gloria Margiotta Casaluci, MD^13*, Vittorio Ruggero Zilioli^14*, Manuela Zanni, MD^15*, Gerardo Musuraca, M.D., Ph.D.^16*, Anna Merli^17*, Benedetta Bianchi, MD^18*, Silvia Bolis, MD^19*, Vincenzo Pavone, MD^20*, Annalisa Chiarenza^21*, Annalisa Arcari^22*, Catello Califano, MD^23*, Samantha Pozzi, MD^24*, Massimo Massaia²⁵, Annarita Conconi^26*, Tommasina Perrone, MD^27*, Donato Mannina^28*, Alessandro Re, MD^29*, Maria Elena Nizzoli, MD^30*, Dimitri Dardanis^4*, Stefano Luminari^30,31 and Marco Ladetto, MD³²

¹Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy
²Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, Italy
³Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
⁴Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
⁵Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy
⁶Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
⁷AIL Roma Odv, Rome, Italy
⁸SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
⁹SC Ematologia, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
¹⁰Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹¹Department of Molecular Medicine, University of Pavia, Pavia, Italy
¹²IRCCS Ospedale Policlinico San Martino, Genoa, Italy
¹³Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
¹⁴Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy, Milano, IT-MI, Italy
¹⁵Dipartimento di Medicina Traslazionale Università del Piemonte Orientale e SCDU Ematologia, Az Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁶IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
¹⁷Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, ITA
¹⁸Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, Varese, Italy
¹⁹Fondazione Irccs San Gerardo, SC di Ematologia, Monza, Italy
²⁰Hematology Unit, Azienda C. Panico, Tricase, Italy
²¹A.O.U. Policlinico "G. Rodolico-S.Marco", Catania, U.O.C. Ematologia, Catania, Italy
²²UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
²³EMATOLOGIA, ASL SALERNO, PRESIDIO OSPEDALIERO TORTORA PAGANI, Pagani, ITA
²⁴Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia, Modena, Italy., Modena, Italy
²⁵SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
²⁶SSD Ematologia, Nuovo Ospedale degli Infermi, Biella, Italy
²⁷Department of Precision and Regenerative Medicine and Ionian Area, Unit of Hematology with Transplantation, Bari, Italy
²⁸UOC di Ematologia, Dipartimento Oncoematologico, Azienda Ospedaliera Papardo, Messina, Messina, Italy
²⁹Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
³⁰Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
³¹Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy
³²Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy

Lorenzo Falchi, MD¹, Michelle Okwali, MPH^1*, Alexandra Ferreira Lopes, BS^2*, Paul A. Hamlin, MD¹, Jennifer Kimberly Lue, MD¹, Paola Ghione, MD¹, Colette Owens, MD¹, Pallawi Torka, MD², Anita Kumar, MD¹, Raphael Steiner, MD^1*, Zachary D. Epstein-Peterson, MD³, Maria Lia Palomba, MD¹, Robert Stuver, MD¹, Ariela Noy, MD⁴, Anastasia Martinova, BSN, RN^5*, Lauren Wood, MSN, RN, AGCNS-BC, OCN^5*, Clare Grieve, MPH^2*, Walter Ramos Amador, MPH, MS^2*, Santosha A. Vardhana, MD, PhD⁶, Andrew D. Zelenetz, MD, PhD¹, Lori A. Leslie, MD⁷, Joseph L. Roswarski, MD⁸, Kieron Dunleavy, MD^9*, Andre Goy, MD, MS¹⁰ and Gilles Salles, MD, PhD¹

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, New York, NY
⁴Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY
⁵Memorial Sloan Kettering Cancer Center, New York
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁷Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁸Hematologic Malignancies Department, Medstar Georgetown University Hospital, Washington, DC
⁹Medstar Georgetown University Hospital, Washington, DC
¹⁰Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Jing-Zhou Hou, MD, PhD¹, Ranjit Nair, MD², Ryan Jacobs, MD³, Tae Min Kim, MD, PhD^4*, Seok-Goo Cho^5*, Dai Maruyama, MD, PhD⁶, Sumana Devata, MD⁷, Yazeed Sawalha, MD⁸, Dok Hyun Yoon, MD, PhD⁹, Constantine S. Tam, MD, MBBS¹⁰, Koji Izutsu, MD, PhD¹¹, Matthew Matasar, MD, MS¹², Don A. Stevens, MD¹³, Aravind Ramakrishnan, MD¹⁴, Denise Brennan^15*, Xu (sue) Zhu^15*, Robin Lesley, PhD^16*, Yasuhiro Oki, MD¹⁶, David Sermer^17* and Sameh Gaballa, MD¹⁸

¹Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Atrium Health Levine Cancer Institute, Charlotte, NC
⁴Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁶Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁷Medical College of Wisconsin, Milwaukee, WI
⁸The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁹Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
¹⁰Alfred Hospital and Monash University, Melbourne, VIC, Australia
¹¹National Cancer Center Hospital, Tokyo, Japan
¹²Rutgers Cancer Institute, New Brunswick, NJ
¹³Norton Cancer Institute, Norton Health Care, Louisville, KY
¹⁴Sarah Cannon Transplant and Cellular Therapy, St. David’s South Austin Medical Center, Austin, TX
¹⁵AstraZeneca, Waltham, MA
¹⁶AstraZeneca, South San Francisco, CA
¹⁷AstraZeneca, New York, NY
¹⁸H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Lorenzo Falchi, MD¹, Anna Sureda Balari, MD, PhD², Sirpa Leppä, MD PhD^3*, Joost S.P. Vermaat⁴, Marcel Nijland, MD, PhD^5*, Jacob Haaber Christensen, MD, PhD^6*, Sven de Vos, MD, PhD^7*, Harald Holte, MD, PhD⁸, Reid W. Merryman, MD⁹, Pieternella Lugtenburg, MD, PhD¹⁰, Pau Abrisqueta Costa, MD, PhD^11*, Kim Linton^12*, Gauri Sunkersett, DO^13*, Christopher Morehouse, MS^14*, Andrew J. Steele, PhD^14*, Jennifer Marek^14*, Liwei Wang, PhD^14*, Daniela Hoehn, MD, PhD^14*, Martin Hutchings, MD, PhD¹⁵ and David Belada, MD, PhD¹⁶

¹Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Clinical Hematology Department, Institut Català d’Oncologia – L’Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
³University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁴Leiden University Medical Center, Leiden, Netherlands
⁵University Medical Center Groningen and University of Groningen, Groningen, Netherlands
⁶Odense University Hospital, Odense, Denmark
⁷Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA
⁸Oslo University Hospital and KG Jebsen Center for B-cell Malignancies, Oslo, Norway
⁹Dana-Farber Cancer Institute, Boston, MA
¹⁰On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands
¹¹Hospital Universitario Vall d’Hebro, Barcelona, Spain
¹²The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
¹³AbbVie, North Chicago, IL
¹⁴Genmab, Plainsboro, NJ
¹⁵Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
¹⁶4th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic